up

Over the past year, Nvidia has traded in a range of $8.65 to $26.17 and is now at $23.10, 167% above that low. The 200-day and 50-day moving averages have moved 0.93% higher and 3.69% higher over the past week, respectively.

Shares of Nvidia (NASDAQ:NVDA) have bearishly opened below the pivot of $24.14 today and have reached the first support level of $23.50. Analysts will be watching for a cross of the next downside pivot targets of $23.12 and $22.09

Pfizer share prices have moved between a 52-week high of $19.39 and a 52-week low of $14.00 and are now trading 35% above that low price at $18.95 per share. Over the last five market days, the 200-day moving average (MA) has gone

Shares of Pfizer (NYSE:PFE) opened today below their pivot of $19.11 and have already reached the first level of support at $19.04. Investors may be interested in a cross of the next downside pivot targets of $18.93 and $18.74.

Citigroup share prices have moved between a 52-week high of $5.15 and a 52-week low of $3.11 and are now trading 55% above that low price at $4.83 per share. Over the last five market days, the 200-day moving average (MA) has rema

Shares of Citigroup (NYSE:C) opened today below their pivot of $4.89 and have already reached the first level of support at $4.86. Investors may be interested in a cross of the next downside pivot targets of $4.83 and $4.77.

A 13.9% potential upside exists for Wells Fargo, based on a current level of $33.09 and analysts' average consensus price target of $37.69. The stock should discover initial support at its 50-day moving average (MA) of $31.12 and

Shares of Wells Fargo (NYSE:WFC) opened today below their pivot of $33.85 and have already reached the first level of support at $33.45. Investors may be interested in a cross of the next downside pivot targets of $32.80 and $31.7

In the past 52 weeks, Morgan Stanley share prices have been bracketed by a low of $22.40 and a high of $32.29 and are now at $29.92, 34% above that low price. Over the past week, the 200-day moving average (MA) has remained consta

Morgan Stanley (NYSE:MS) has opened bearishly below the pivot of $30.60 today and has reached the first level of support at $30.32. Should the shares continue to fall, the support pivots of $30.01 and $29.42 will be of interest.

In the past 52 weeks, shares of Yahoo! have traded between a low of $12.94 and a high of $19.12 and are now at $16.54, which is 28% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbe

Shares of Yahoo! (NASDAQ:YHOO) have bearishly opened below the pivot of $16.64 today and have reached the first support level of $16.43. Analysts will be watching for a cross of the next downside pivot targets of $16.27 and $15.90

A 13.7% potential upside exists for Alcoa, based on a current level of $17.19 and analysts' average consensus price target of $19.55. The stock should discover initial support at its 50-day moving average (MA) of $15.51 and subseq

Shares of Alcoa (NYSE:AA) opened today below their pivot of $17.36 and have already reached the first level of support at $17.25. Investors may be interested in a cross of the next downside pivot targets of $17.08 and $16.80.

The company posted record revenue of $33.8 million for the fourth quarter ended Dec. 31, a 29% increase over the $26.2 million reported for the same period in 2009. Net income was $4.3 million for the fourth quarter, or $0.20 per

Shares of Stratasys (SSYS) are up $4.80 to $40.18, or 11.61%, after the company reported strong fourth quarter and full year financial results that surpassed market expectations.

Morgan Stanley lowered its 2011 and 2012 EPS estimates for Teva Pharmaceutical Industries (NASDAQ:TEVA) and maintained its equal-weight rating. The bank sees 2011 EPS of $5.05, down from $5.29 per share, and 2012 EPS of $5.78, do

The bank sees 2012 EPS of $1.98, up from $1.97 per share.

Illumina has a potential upside of 5% based on a current price of $70.25 and an average consensus analyst price target of $73.73.

Illumina is currently above its 50-day moving average (MA) of $66.13 and above its 200-day of $51.55.

Morgan Stanley raised its 2012 EPS estimate for Illumina (NASDAQ:ILMN) and maintained its overweight rating and $78 price target.